Efficacy and safety of first line oral therapies in relapsing-remitting multiple sclerosis: Dimethyl fumarate vs teriflunomide in the Chieti experience

被引：0
|
作者：
Di Tommaso, V. [1 ]
Mancinelli, L. [2 ]
di Ioia, M. [2 ]
Farina, D. [2 ]
Travaglini, D. [2 ]
Pietrolongo, E. [2 ]
De Luca, G. [2 ]
Lugaresi, A. [3 ]
机构：
[1] MS Ctr, Chieti, Italy
[2] G DAnnunzio, Chieti, Italy
[3] Univ Bologna, Alma Mater Studiorum, Bologna, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1648
引用
收藏
页码：870 / 871
页数：2
相关论文
共 50 条
  • [1] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: the Chieti experience
    di Ioia, M.
    Travaglini, D.
    Di Tommaso, V.
    Mancinelli, L.
    Pietrolongo, E.
    De Luca, G.
    Farina, D.
    Lugaresi, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 754 - 754
  • [2] Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Nehzat, Nasim
    Mirmosayyeb, Omid
    Barzegar, Mahdi
    Vosoughi, Reza
    Fazeli, Erfane
    Shaygannejad, Vahid
    [J]. NEUROLOGY RESEARCH INTERNATIONAL, 2021, 2021
  • [3] Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis
    Muller, Jannis
    Schadelin, Sabine
    Lorscheider, Johannes
    Benkert, Pascal
    Hanni, Peter
    Schmid, Jurg
    Kuhle, Jens
    Derfuss, Tobias
    Granziera, Cristina
    Yaldizli, Ozgur
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3809 - 3818
  • [4] Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis
    Mueller, J.
    Schaedelin, S.
    Benkert, P.
    Haenni, P.
    Schmid, J.
    Derfuss, T.
    Kuhle, J.
    Yaldizli, O.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 676 - 676
  • [5] Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis
    Paolicelli, Damiano
    Manni, Alessia
    Iaffaldano, Antonio
    Trojano, Maria
    [J]. CNS DRUGS, 2020, 34 (01) : 65 - 92
  • [6] Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis
    Damiano Paolicelli
    Alessia Manni
    Antonio Iaffaldano
    Maria Trojano
    [J]. CNS Drugs, 2020, 34 : 65 - 92
  • [7] Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience
    D'Amico, Emanuele
    Zanghi, Aurora
    Callari, Graziella
    Borriello, Giovanna
    Gallo, Antonio
    Graziano, Giusi
    Valentino, Paola
    Buccafusca, Maria
    Cottone, Salvatore
    Salemi, Giuseppe
    Ragonese, Paolo
    Bossio, Roberto Bruno
    Docimo, Renato
    Grimaldi, Luigi Maria Edoardo
    Pozzilli, Carlo
    Tedeschi, Gioacchino
    Zappia, Mario
    Patti, Francesco
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [8] Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis
    Oh, Jiwon
    O'Connor, Paul W.
    [J]. CNS DRUGS, 2013, 27 (08) : 591 - 609
  • [9] Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis
    Jiwon Oh
    Paul W. O’Connor
    [J]. CNS Drugs, 2013, 27 : 591 - 609
  • [10] Real world experience with dimethyl fumarate in relapsing-remitting multiple sclerosis
    Cox, S. R.
    Jordan, S.
    Sharma, D.
    O'Boyle, G.
    Tubridy, N.
    Hutchinson, M.
    Mcguigan, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 614 - 615
12345